These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14575803)
1. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice. Tomimori Y; Muto T; Saito K; Tanaka T; Maruoka H; Sumida M; Fukami H; Fukuda Y Eur J Pharmacol; 2003 Oct; 478(2-3):179-85. PubMed ID: 14575803 [TBL] [Abstract][Full Text] [Related]
2. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice. Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860 [TBL] [Abstract][Full Text] [Related]
3. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734 [TBL] [Abstract][Full Text] [Related]
4. Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice. Shiota N; Kakizoe E; Shimoura K; Tanaka T; Okunishi H Br J Pharmacol; 2005 Jun; 145(4):424-31. PubMed ID: 15806109 [TBL] [Abstract][Full Text] [Related]
11. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [TBL] [Abstract][Full Text] [Related]
12. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408 [TBL] [Abstract][Full Text] [Related]
13. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. Lindstedt KA; Wang Y; Shiota N; Saarinen J; Hyytiäinen M; Kokkonen JO; Keski-Oja J; Kovanen PT FASEB J; 2001 Jun; 15(8):1377-88. PubMed ID: 11387235 [TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways. Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203 [TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720 [TBL] [Abstract][Full Text] [Related]
17. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis. Howard PS; Renfrow D; Schechter NM; Kucich U Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657 [TBL] [Abstract][Full Text] [Related]
18. [Effects of cordyceps sinensi on bleomycin-induced pulmonary fibrosis in mice]. Wang SJ; Bai W; Wang CL; Dai Z Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(24):2623-7. PubMed ID: 18338602 [TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
20. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice. Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]